Cancer vaccine impact limited unless drug industry focuses on difficult-to-treat tumors, experts say

Drug companies currently developing therapeutic cancer vaccines may be determining the cancers they target based on the number of annual cases, not the number of deaths they cause. This approach may limit the patient benefits of such drugs, according to a new University of Michigan report.

Read the whole article on Science Daily

More from Science Daily